You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

GLIPIZIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for glipizide and what is the scope of freedom to operate?

Glipizide is the generic ingredient in five branded drugs marketed by Aurobindo Pharma, Endo Operations, Norvium Bioscience, Unique, Watson Labs, Zydus Pharms, Pfizer, Accord Hlthcare, Ani Pharms, Apotex, Aurobindo Pharma Usa, Barr Labs Inc, Chartwell Rx, Oxford Pharms, Rubicon, Sandoz, Sun Pharm Inds Inc, Watson Labs Teva, Dash Pharms, Epic Pharma Llc, Heritage, Teva Pharms, Zydus Pharms Usa Inc, and Bristol Myers Squibb, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for glipizide. Forty-three suppliers are listed for this compound.

Drug Prices for GLIPIZIDE

See drug prices for GLIPIZIDE

Drug Sales Revenue Trends for GLIPIZIDE

See drug sales revenues for GLIPIZIDE

Recent Clinical Trials for GLIPIZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Memorial Sloan Kettering Cancer CenterPhase 2
University of MichiganPhase 1
Food and Drug Administration (FDA)Phase 1

See all GLIPIZIDE clinical trials

Pharmacology for GLIPIZIDE
Drug ClassSulfonylurea
Medical Subject Heading (MeSH) Categories for GLIPIZIDE

US Patents and Regulatory Information for GLIPIZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unique GLIPIZIDE glipizide TABLET, EXTENDED RELEASE;ORAL 204720-002 Dec 29, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz GLIPIZIDE glipizide TABLET;ORAL 074305-002 Apr 7, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz GLIPIZIDE glipizide TABLET;ORAL 074305-001 Apr 7, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dash Pharms GLIPIZIDE AND METFORMIN HYDROCHLORIDE glipizide; metformin hydrochloride TABLET;ORAL 078083-002 Apr 12, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Unique GLIPIZIDE glipizide TABLET, EXTENDED RELEASE;ORAL 204720-001 Dec 29, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Teva GLIPIZIDE glipizide TABLET;ORAL 074223-001 Feb 27, 1995 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms GLIPIZIDE AND METFORMIN HYDROCHLORIDE glipizide; metformin hydrochloride TABLET;ORAL 077270-002 Oct 28, 2005 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for GLIPIZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-002 Apr 26, 1994 ⤷  Sign Up ⤷  Sign Up
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994 ⤷  Sign Up ⤷  Sign Up
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994 ⤷  Sign Up ⤷  Sign Up
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-003 Aug 10, 1999 ⤷  Sign Up ⤷  Sign Up
Pfizer GLUCOTROL glipizide TABLET;ORAL 017783-002 May 8, 1984 ⤷  Sign Up ⤷  Sign Up
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-002 Apr 26, 1994 ⤷  Sign Up ⤷  Sign Up
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-003 Aug 10, 1999 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.